Literature DB >> 7864263

Course and outcome in bipolar affective disorder: a longitudinal follow-up study.

J F Goldberg1, M Harrow, L S Grossman.   

Abstract

OBJECTIVE: A number of recent studies have questioned whether, despite modern treatment, the natural course of bipolar illness today still involves multiple relapses and impaired psychosocial functioning. This prospective follow-up study examined longitudinal outcome in a large group of inpatients with affective disorders.
METHOD: Fifty-one bipolar manic patients and 49 unipolar depressed patients were interviewed three times: 1) during hospitalization, 2) approximately 2 years after discharge, and 3) approximately 4.5 years after discharge. Subjects were treated under routine conditions and assessed for global adjustment, rehospitalization, and work and social functioning.
RESULTS: Only 41% of the bipolar group had a good overall outcome by the time of the 4.5-year follow-up. The bipolar patients had more severe work impairment than the unipolar group. More than one-half of the bipolar patients were rehospitalized at least once during the 4.5-year follow-up period. Outcome for both diagnostic groups improved significantly over time.
CONCLUSIONS: Many contemporary bipolar patients demonstrate gradual improvement in the first several years after hospitalization. However, a subgroup approaching 60% still experience poor posthospital adjustment in one or more areas of functioning.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864263     DOI: 10.1176/ajp.152.3.379

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  47 in total

Review 1.  Functional impairment and cognition in bipolar disorder.

Authors:  C A Zarate; M Tohen; M Land; S Cavanagh
Journal:  Psychiatr Q       Date:  2000

2.  Emotion in bipolar I disorder: Implications for functional and symptom outcomes.

Authors:  Sheri L Johnson; Jordan A Tharp; Andrew D Peckham; Kaja J McMaster
Journal:  J Abnorm Psychol       Date:  2015-10-19

3.  Psychotherapy for Bipolar Disorder in Adults: A Review of the Evidence.

Authors:  Holly A Swartz; Joshua Swanson
Journal:  Focus (Am Psychiatr Publ)       Date:  2014

Review 4.  Polytherapy in bipolar disorder.

Authors:  Daniel Lin; Hiram Mok; Lakshmi N Yatham
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials.

Authors:  Dennis A Revicki; Louis S Matza; Emuella Flood; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 6.  Epidemiology and burden of bipolar disorder in Africa: a systematic review of data from Africa.

Authors:  Oluyomi Esan; Arinola Esan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-09       Impact factor: 4.328

7.  Descriptive study of the occupational outcome of bipolar patients.

Authors:  E Medard; C Dubertret; C S Peretti; J Ades; A D'escatha
Journal:  J Occup Rehabil       Date:  2010-09

8.  Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.

Authors:  Marie de Zelicourt; Roland Dardennes; Hélène Verdoux; Gian Gandhi; Babak Khoshnood; Eric Chomette; Marie-Laure Papatheodorou; Eric T Edgell; Christian Even; Francis Fagnani
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder.

Authors:  Ellen Frank; Isabella Soreca; Holly A Swartz; Andrea M Fagiolini; Alan G Mallinger; Michael E Thase; Victoria J Grochocinski; Patricia R Houck; David J Kupfer
Journal:  Am J Psychiatry       Date:  2008-10-01       Impact factor: 18.112

10.  Psychosocial correlates of subsyndromal symptoms and functioning of bipolar patients stabilized on prophylactic lithium.

Authors:  D Kumar; D Basu; P Kulhara; P Sharan
Journal:  Indian J Psychiatry       Date:  2001-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.